- Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
-
Kim JH
- KMID: 2174025
- Diabetes Metab J.
- 2015 Aug;39(4):304-306.
- doi: 10.4093/dmj.2015.39.4.304
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
-
Lee DH
- KMID: 2174032
- Diabetes Metab J.
- 2015 Aug;39(4):348-349.
- doi: 10.4093/dmj.2015.39.4.348
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
-
Suh S, Seo GH, Jung CH, Kim MK, Jin SM, Hwang YC, Lee BW, Kim JH
- KMID: 2174033
- Diabetes Metab J.
- 2015 Aug;39(4):350-351.
- doi: 10.4093/dmj.2015.39.4.350
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
-
Rhee SY, Kim YS
- KMID: 2174023
- Diabetes Metab J.
- 2015 Aug;39(4):283-290.
- doi: 10.4093/dmj.2015.39.4.283
Peripheral arterial disease (PAD) in patients with type 2 diabetes mellitus (T2DM) exhibits broad clinical characteristics and various consequences and is known as one of the major macrovascular complications of... -
- CITED
-
- Close
- SHARE
-
- Close
- Glycemic Variability: How Do We Measure It and Why Is It Important?
-
Suh S, Kim JH
- KMID: 2174022
- Diabetes Metab J.
- 2015 Aug;39(4):273-282.
- doi: 10.4093/dmj.2015.39.4.273
Chronic hyperglycemia is the primary risk factor for the development of complications in diabetes mellitus (DM); however, it is believed that frequent or large glucose fluctuations may independently contribute to... -
- CITED
-
- Close
- SHARE
-
- Close
- Maternal and Neonatal Outcomes in Korean Women with Type 1 and Type 2 Diabetes
-
Kim HS, Jang HJ, Park JE, Kim MY, Ko SY, Kim SH
- KMID: 2174027
- Diabetes Metab J.
- 2015 Aug;39(4):316-320.
- doi: 10.4093/dmj.2015.39.4.316
BACKGROUND: The purpose of this study was to evaluate maternal and neonatal outcomes in Korean women with type 1 diabetes and type 2 diabetes. METHODS: We performed a retrospective survey of... -
- CITED
-
- Close
- SHARE
-
- Close
- Maximal Fat Oxidation Rate during Exercise in Korean Women with Type 2 Diabetes Mellitus
-
Suk MH, Moon YJ, Park SW, Park CY, Shin YA
- KMID: 2174029
- Diabetes Metab J.
- 2015 Aug;39(4):328-334.
- doi: 10.4093/dmj.2015.39.4.328
BACKGROUND: The purpose of this study was to determine the appropriate exercise intensity associated with maximum fat oxidation, improvement of body composition, and metabolic status in Korean women with type... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus
-
Yang HK, Kang B, Lee SH, Kim HS, Yoon KH, Cha BY, Cho JH
- KMID: 2174030
- Diabetes Metab J.
- 2015 Aug;39(4):335-341.
- doi: 10.4093/dmj.2015.39.4.335
BACKGROUND: This study aimed to evaluate the effect of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, on insulin secretion and glucagon suppression in Korean subjects with type 2 diabetes mellitus. METHODS: Twenty-four... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
-
Yagi S, Aihara KI, Akaike M, Fukuda D, Salim HM, Ishida M, Matsuura T, Ise T, Yamaguchi , Iwase T, Yamada H, Soeki T, Wakatsuki , Shimabukuro M, Matsumoto , Sata M
- KMID: 2174031
- Diabetes Metab J.
- 2015 Aug;39(4):342-347.
- doi: 10.4093/dmj.2015.39.4.342
BACKGROUND: Predictive factors for the efficacy of dipeptidyl peptidase-4 (DPP-4) inhibitors for lowering glycosylated hemoglobin (HbA1c) remain unclear in patients with type 2 diabetes mellitus. The aim of this study... -
- CITED
-
- Close
- SHARE
-
- Close
- Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population
-
Bansal D, Nayakallu , Gudala K, Vyamasuni , Bhansali A
- KMID: 2174028
- Diabetes Metab J.
- 2015 Aug;39(4):321-327.
- doi: 10.4093/dmj.2015.39.4.321
BACKGROUND: The aim of the study is to evaluate the concurrence between Framingham Risk score (FRS) and United Kingdom Prospective Diabetes Study (UKPDS) risk engine in identifying coronary heart disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Probiotics as Complementary Treatment for Metabolic Disorders
-
Le Barz M, Anhe FF, Varin TV, Desjardins Y, Levy E, Roy D, Urdaci MC, Marette A
- KMID: 2174024
- Diabetes Metab J.
- 2015 Aug;39(4):291-303.
- doi: 10.4093/dmj.2015.39.4.291
Over the past decade, growing evidence has established the gut microbiota as one of the most important determinants of metabolic disorders such as obesity and type 2 diabetes. Indeed, obesogenic... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea
-
Jung JH, Lee JH, Noh JW, Park JE, Kim HS, Yoo JW, Song BR, Lee JR, Hong MH, Jang HM, Na Y, Lee HJ, Lee JM, Kang YG, Kim SY, Sim KH
- KMID: 2174026
- Diabetes Metab J.
- 2015 Aug;39(4):307-315.
- doi: 10.4093/dmj.2015.39.4.307
BACKGROUND: In Korea, the prevalence, complications, and mortality rate of diabetes are rapidly increasing. However, investigations on the actual condition of diabetes management are very limited due to lack of... -
- CITED
-
- Close
- SHARE
-
- Close
